182 related articles for article (PubMed ID: 20491793)
1. Failure of regulation results in an amplified oxidation burst by neutrophils in children with primary nephrotic syndrome.
Bertelli R; Trivelli A; Magnasco A; Cioni M; Bodria M; Carrea A; Montobbio G; Barbano G; Ghiggeri GM
Clin Exp Immunol; 2010 Jul; 161(1):151-8. PubMed ID: 20491793
[TBL] [Abstract][Full Text] [Related]
2. Regulation of innate immunity by the nucleotide pathway in children with idiopathic nephrotic syndrome.
Bertelli R; Bodria M; Nobile M; Alloisio S; Barbieri R; Montobbio G; Patrone P; Ghiggeri GM
Clin Exp Immunol; 2011 Oct; 166(1):55-63. PubMed ID: 21762125
[TBL] [Abstract][Full Text] [Related]
3. Toll-like receptor 3 expression and function in childhood idiopathic nephrotic syndrome.
Jamin A; Dehoux L; Dossier C; Fila M; Heming N; Monteiro RC; Deschênes G
Clin Exp Immunol; 2015 Dec; 182(3):332-45. PubMed ID: 26123900
[TBL] [Abstract][Full Text] [Related]
4. Randomised controlled trial comparing ofatumumab to rituximab in children with steroid-dependent and calcineurin inhibitor-dependent idiopathic nephrotic syndrome: study protocol.
Ravani P; Bonanni A; Ghiggeri GM
BMJ Open; 2017 Mar; 7(3):e013319. PubMed ID: 28314744
[TBL] [Abstract][Full Text] [Related]
5. [Oxidative potential of neutrophils in cyclosporine A treated children with idiopathic nephrotic syndrome].
Tkaczyk M; Lewkowicz P; Nowicki M; Tchórzewski H; Baj Z
Pol Merkur Lekarski; 2004 Oct; 17(100):331-4. PubMed ID: 15690694
[TBL] [Abstract][Full Text] [Related]
6. Adverse events linked with the use of chimeric and humanized anti-CD20 antibodies in children with idiopathic nephrotic syndrome.
Bonanni A; Calatroni M; D'Alessandro M; Signa S; Bertelli E; Cioni M; Di Marco E; Biassoni R; Caridi G; Ingrasciotta G; Bertelli R; Di Donato A; Bruschi M; Canepa A; Piaggio G; Ravani P; Ghiggeri GM
Br J Clin Pharmacol; 2018 Jun; 84(6):1238-1249. PubMed ID: 29436729
[TBL] [Abstract][Full Text] [Related]
7. Impact of MPO-ANCA-mediated oxidative imbalance on renal vasculitis.
Hilhorst M; Maria AT; Kavian N; Batteux F; Borderie D; Le Quellec A; van Paassen P; Guilpain P
Am J Physiol Renal Physiol; 2018 Dec; 315(6):F1769-F1776. PubMed ID: 30207165
[TBL] [Abstract][Full Text] [Related]
8. Rituximab in idiopathic nephrotic syndrome: does it make sense?
Cara-Fuentes G; Kairalla JA; Ishimoto T; Rivard C; Johnson RJ; Garin EH
Pediatr Nephrol; 2014 Aug; 29(8):1313-9. PubMed ID: 23793923
[TBL] [Abstract][Full Text] [Related]
9. Podocyte sphingomyelin phosphodiesterase acid-like 3b decreases among children with idiopathic nephrotic syndrome.
Watanabe S; Hirono K; Aizawa T; Tsugawa K; Joh K; Imaizumi T; Tanaka H
Clin Exp Nephrol; 2021 Jan; 25(1):44-51. PubMed ID: 32946006
[TBL] [Abstract][Full Text] [Related]
10. Neutrophil priming and apoptosis in anti-neutrophil cytoplasmic autoantibody-associated vasculitis.
Harper L; Cockwell P; Adu D; Savage CO
Kidney Int; 2001 May; 59(5):1729-38. PubMed ID: 11318943
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of rituximab treatment in children with primary glomerulonephritis.
Zachwieja J; Silska M; Ostalska-Nowicka D; Soltysiak J; Lipkowska K; Blumczynski A; Musielak A
J Nephrol; 2012; 25(6):1060-6. PubMed ID: 22322817
[TBL] [Abstract][Full Text] [Related]
12. Interstitial Immunostaining and Renal Outcomes in Antineutrophil Cytoplasmic Antibody-Associated Glomerulonephritis.
Geetha D; Sethi S; De Vriese AS; Specks U; Kallenberg CGM; Lim N; Spiera R; St Clair EW; Merkel PA; Seo P; Monach PA; Lepori N; Fessler BJ; Langford CA; Hoffman GS; Sharma R; Stone JH; Fervenza FC;
Am J Nephrol; 2017; 46(3):231-238. PubMed ID: 28881339
[TBL] [Abstract][Full Text] [Related]
13. ANCA-positive pauci-immune rapidly progressive glomerulonephritis and the nephrotic syndrome.
Jabur WL; Saeed HM
Saudi J Kidney Dis Transpl; 2010 May; 21(3):526-30. PubMed ID: 20427883
[TBL] [Abstract][Full Text] [Related]
14. Chronic oxidative stress reduces the respiratory burst response of neutrophils from beta-thalassaemia patients.
Amer J; Fibach E
Br J Haematol; 2005 May; 129(3):435-41. PubMed ID: 15842669
[TBL] [Abstract][Full Text] [Related]
15. Anti-CD20 Antibodies for Idiopathic Nephrotic Syndrome in Children.
Ravani P; Bonanni A; Rossi R; Caridi G; Ghiggeri GM
Clin J Am Soc Nephrol; 2016 Apr; 11(4):710-20. PubMed ID: 26585985
[TBL] [Abstract][Full Text] [Related]
16. Rituximab for Steroid-Dependent or Frequently Relapsing Idiopathic Nephrotic Syndrome in Adults: A Retrospective, Multicenter Study in Spain.
DaSilva I; Huerta A; Quintana L; Redondo B; Iglesias E; Draibe J; Praga M; Ballarín J; Díaz-Encarnación M;
BioDrugs; 2017 Jun; 31(3):239-249. PubMed ID: 28534103
[TBL] [Abstract][Full Text] [Related]
17. C5a receptor 1 promotes autoimmunity, neutrophil dysfunction and injury in experimental anti-myeloperoxidase glomerulonephritis.
Dick J; Gan PY; Ford SL; Odobasic D; Alikhan MA; Loosen SH; Hall P; Westhorpe CL; Li A; Ooi JD; Woodruff TM; Mackay CR; Kitching AR; Hickey MJ; Holdsworth SR
Kidney Int; 2018 Mar; 93(3):615-625. PubMed ID: 29241626
[TBL] [Abstract][Full Text] [Related]
18. Regulatory T cells and CTLA-4 in idiopathic nephrotic syndrome.
Tsuji S; Kimata T; Yamanouchi S; Kitao T; Kino J; Suruda C; Kaneko K
Pediatr Int; 2017 May; 59(5):643-646. PubMed ID: 28544686
[TBL] [Abstract][Full Text] [Related]
19. Impaired phagocytosis and reactive oxygen species production in phagocytes is associated with systemic vasculitis.
Johansson ÅC; Ohlsson S; Pettersson Å; Bengtsson AA; Selga D; Hansson M; Hellmark T
Arthritis Res Ther; 2016 Apr; 18():92. PubMed ID: 27102815
[TBL] [Abstract][Full Text] [Related]
20. Rituximab treatment for severe steroid- or cyclosporine-dependent nephrotic syndrome: a multicentric series of 22 cases.
Guigonis V; Dallocchio A; Baudouin V; Dehennault M; Hachon-Le Camus C; Afanetti M; Groothoff J; Llanas B; Niaudet P; Nivet H; Raynaud N; Taque S; Ronco P; Bouissou F
Pediatr Nephrol; 2008 Aug; 23(8):1269-79. PubMed ID: 18465150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
